SCI-110 in the Treatment of Tourette Syndrome

Clinical trial NCT05126888 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05126888
Sponsor: Neurothera Labs Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tourette Syndrome

Start date: 2026-06-01
Primary completion: 2027-10-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.